Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC101927746 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
IFT22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FIS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLDN15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNHIT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLOD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MOGAT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAT16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COL26A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VGF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AP1S1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01007 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYL10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CUX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on